Notably, clinicians noted that if his current intake patterns are sustained for a full year, his projected AUDIT score would drop to 1, indicating low risk
Cardiovascular safety of antidiabetic medications has received increasing attention since 2008 and here we summarize the recent updates from both clinical trials and preclinical experiments on the cardiovascular outcomes of this class of glucose-lowering drugs
You might be looking at the wrong side to reduce your fats, whereas your weight gain starts with your Carbs
GSH levels have been shown to decrease with ageing and in several age-related degenerative diseases and AD in particular (Harris et al., 2015
We assume that Novo Nordisk is capable of growing GLP-1 sales across indications from roughly $24 billion in 2023 to nearly $75 billion by 2031, prior to the patent expiration for semaglutide, the molecule in Ozempic and Wegovy
At 5 mg/mL, 40 units delivers 2.0 mg, a high dose near the maximum approved maintenance level of 2.4 mg